Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Author(s) -
David J. Stott,
Nicolas Rodondi,
Patricia M. Kearney,
Ian Ford,
Rudi G. J. Westendorp,
Simon P. Mooijaart,
Naveed Sattar,
Carole E. Aubert,
Drahomir Aujesky,
Douglas C. Bauer,
Christine Baumgartner,
Manuel R. Blum,
John Browne,
Stephen Byrne,
TinhHai Collet,
Olaf M. Dekkers,
Wendy P. J. den Elzen,
Robert S. Du Puy,
Graham Ellis,
Martin Feller,
Carmen Floriani,
Kirsty Hendry,
Caroline Hurley,
J. Wouter Jukema,
Sharon Kean,
Maria D. Kelly,
Danielle L. Krebs,
Peter Langhorne,
Gemma McCarthy,
Vera J. C. Mc Carthy,
Alex McConnachie,
Mairi McDade,
ClaudiaMartina Messow,
Annemarie O’Flynn,
David L. O’Riordan,
Rosalinde K.E. Poortvliet,
Terence J. Quinn,
Audrey Russell,
Carol Sinnott,
Johannes W. A. Smit,
H.A. van Dorland,
Kieran Walsh,
Elaine Walsh,
Torquil Watt,
Robbie Wilson,
Jacobijn Gussekloo
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1603825
Subject(s) - levothyroxine , medicine , subclinical infection , liter , placebo , thyroid , randomized controlled trial , thyroid disease , pediatrics , alternative medicine , pathology
The use of levothyroxine to treat subclinical hypothyroidism is controversial. We aimed to determine whether levothyroxine provided clinical benefits in older persons with this condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom